Title : Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment.

Pub. Date : 2020

PMID : 32021192






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In vivo experiments, DNR-CdTe-CD123 can effectively inhibit the tumor growth of MDS-bearing nude mice and reduce the side effects of DNR on myocardial cells. Daunorubicin interleukin 3 receptor, alpha chain Mus musculus
2 Conclusion: The system of DNR-CdTe-CD123 enhances the therapeutic effects and reduce the side effects of DNR, thus providing a novel platform for MDS treatment. Daunorubicin interleukin 3 receptor, alpha chain Mus musculus